Impact of Beers Criteria Medications in Elderly Patients With Head and Neck Cancer
- 12 August 2026
- journal article
- Published by Wiley in Head & Neck
Abstract
Background: Head and neck cancer patients often experience polypharmacy due to complex treatments and comorbidities. The Beers Criteria is a list of potentially inappropriate medications (PIMs) for patients above age 65 developed by the American Geriatrics Society. We hypothesize that increased use of PIMs will be associated with inferior health and quality of life outcomes in elderly patients with head and neck cancer. Methods: We retrospectively examined patients aged ≥ 65 years with head and neck cancer diagnosed between 2011 and 2015 using SEER‐Medicare data, analyzing associations between Beers Criteria Medications (BCMs) and survival as a primary outcome. Emergency department (ED) utilization served as a secondary outcome. Results: Among 5213 patients (mean age 72.6 years), 44% received no BCMs within 1 year of diagnosis, while 41.3% received 1 BCM, 9.3% received 2 BCMs, and 5.4% received ≥ 3 BCMs. The most common medications prescribed were Lorazepam (12.3%), Zolpidem (7.9%), and Alprazolam (7.5%). Two‐year survival decreased with BCM use in a dose‐dependent fashion: 88.2% (0 BCM), 86.8% (1 BCM), 86.7% (2 BCMs), and 81.4% (≥ 3 BCMs; p < 0.001). BCM users had higher ED utilization in the year after diagnosis (mean 1.21 vs. 0.95 claims, p = 0.004). Conclusions: BCMs in elderly head and neck cancer patients were associated with inferior survival and increased healthcare utilization. These findings highlight the need for medication reconciliation and systematic reviews by multidisciplinary care teams to optimize outcomes in this vulnerable population.Keywords
Funding Information
- Centers for Disease Control and Prevention (1NU58DP007156)
- University of California, San Francisco (HHSN261201800032I)
- University of Southern California (HHSN261201800015I)
- Public Health Institute (HHSN261201800009I)
This publication has 20 references indexed in Scilit:
- Tackling polypharmacy in geriatric patients: Is increasing physicians’ awareness adequate?Archives of Gerontology and Geriatrics Plus, 2025
- Prevalence of Use of Potentially Inappropriate Medications Among Older Adults WorldwideJAMA Network Open, 2023
- Prophylactic gabapentin during head and neck cancer therapy: a systematic review and meta-analysisSupportive Care in Cancer, 2023
- Association of Polypharmacy with Colorectal Cancer Survival Among Older PatientsThe Oncologist, 2021
- Kidney damage from nonsteroidal anti‐inflammatory drugs—Myth or truth? Review of selected literaturePharmacology Research & Perspectives, 2021
- Polypharmacy in older adults: a narrative review of definitions, epidemiology and consequencesEuropean Geriatric Medicine, 2021
- Potentially inappropriate medication use in older patients with breast and colorectal cancerCancer, 2018
- Effect of polypharmacy and potentially inappropriate medications on treatment and posttreatment courses in elderly patients with head and neck cancerJournal of Cancer Research and Clinical Oncology, 2016
- Using claims data to predict dependency in activities of daily living as a proxy for frailtyPharmacoepidemiology and Drug Safety, 2014
- Nonsteroidal Anti-inflammatory Drugs and Increased Risk of Acute Urinary RetentionArchives of internal medicine (1960), 2005